For citations:
Avdeeva A.S., Lisitsyna T.A., Abramkin A.A., Diatroptov M.E., Nasonov E.L. Dynamics of inflammatory markers and interleukin 6 levels during olokizumab therapy: Results of a single-center randomized controlled trial. Rheumatology Science and Practice. 2026;64(2):160-167. (In Russ.) https://doi.org/10.47360/1995-4484-2026-160-167
JATS XML































